|
|
||||||||
J. Biol. Chem., Vol. 280, Issue 34, 30376-30383, August 26, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
12 Interaction with
SNAP Induces VE-cadherin Localization at Endothelial Junctions and Regulates Barrier Function*







||
From the
Department of Pharmacology, College of Medicine, University of Illinois, Chicago, Illinois 60612 and ¶University of North Carolina, Asheville, North Carolina 28804
The involvement of heterotrimeric G proteins in the regulation of adherens junction function is unclear. We identified
SNAP as an interactive partner of G
12 using yeast two-hybrid screening. glutathione S-transferase pull-down assays showed the selective interaction of
SNAP with G
12 in COS-7 as well as in human umbilical vein endothelial cells. Using domain swapping experiments, we demonstrated that the N-terminal region of G
12 (137 amino acids) was necessary and sufficient for its interaction with
SNAP. G
13 with its N-terminal extension replaced by that of G
12 acquired the ability to bind to
SNAP, whereas G
12 with its N terminus replaced by that of G
13 lost this ability. Using four point mutants of
SNAP, which alter its ability to bind to the SNARE complex, we determined that the convex rather than the concave surface of
SNAP was involved in its interaction with G
12. Co-transfection of human umbilical vein endothelial cells with G
12 and
SNAP stabilized VE-cadherin at the plasma membrane, whereas down-regulation of
SNAP with siRNA resulted in the loss of VE-cadherin from the cell surface and, when used in conjunction with G
12 overexpression, decreased endothelial barrier function. Our results demonstrate a direct link between the
subunit of G12 and
SNAP, an essential component of the membrane fusion machinery, and implicate a role for this interaction in regulating the membrane localization of VE-cadherin and endothelial barrier function.
Received for publication, March 15, 2005 , and in revised form, May 24, 2005.
* This work was supported in part by National Institutes of Health Grants GM56159, GM65160, and HL06078 and by a grant from the American Heart Association (AHA) (to T. V.-Y.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Recipient of AHA Predoctoral Fellowship 0310030Z.
|| To whom correspondence should be addressed: Dept. of Pharmacology (MC 868), University of Illinois, 835 S. Wolcott Ave., Chicago, IL 60612. Tel.: 312-996-9823; Fax: 312-996-1225; E-mail: tvy{at}uic.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
A. V. Andreeva, M. A. Kutuzov, and T. A. Voyno-Yasenetskaya G{alpha}12 is targeted to the mitochondria and affects mitochondrial morphology and motility FASEB J, August 1, 2008; 22(8): 2821 - 2831. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Shasby Cell-cell adhesion in lung endothelium Am J Physiol Lung Cell Mol Physiol, March 1, 2007; 292(3): L593 - L607. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Andreeva, R. Vaiskunaite, M. A. Kutuzov, J. Profirovic, R. A. Skidgel, and T. Voyno-Yasenetskaya Novel Mechanisms of G Protein-Dependent Regulation of Endothelial Nitric-Oxide Synthase Mol. Pharmacol., March 1, 2006; 69(3): 975 - 982. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Bilodeau and H. E. Hamm Endothelial Nitric-Oxide Synthase Reveals a New Face in G Protein Signaling Mol. Pharmacol., March 1, 2006; 69(3): 677 - 679. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |